Showing results (341-350 of 682) with videos related to
Sort By:
Pageof 69
AIDS (London, England)|May 1, 1991
Prevalence of HIV, hepatitis B and associated risk behaviours in clients of a needle-exchange in central LondonG J Hart, N Woodward, A M Johnson, et al.AIDS (London, England)|May 1, 1989
Evaluation of needle exchange in central London: behaviour change and anti-HIV status over one yearG J Hart, A L Carvell, N Woodward, et al.BMJ (Clinical Research Ed.)|November 24, 2001
Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in entrants to Irish prisons: a national cross sectional surveyJ Long, S Allwright, J Barry, et al.Epidemiology and Infection|August 1, 2019
Are there missed opportunities for vaccinating against hepatitis B among people who inject drugs in the UK?J Njoroge, V D Hope, C O'Halloran, et al.Communicable Disease and Public Health|July 21, 2000
Prevalence of HIV, hepatitis B, and hepatitis C antibodies in prisoners in England and Wales: a national surveyA R Weild, O N Gill, D Bennett, et al.The Journal of Antimicrobial Chemotherapy|February 7, 2008
The HIV-1 protease substitution K55R: a protease-inhibitor-associated substitution involved in restoring viral replicationE S Margerison, M Maguire, D Pillay, et al.The Journal of Hygiene|April 1, 1980
Rubella antibody measured by radial haemolysis. Characteristics and performance of a simple screening method for use in diagnostic laboratoriesJ B Kurtz, P P Mortimer, P R Mortimer, et al.Lancet (London, England)|February 23, 1985
Human parvovirus arthropathyD G White, A D Woolf, P P Mortimer, et al.Vox Sanguinis|January 1, 1990
Transmission of human parvovirus B19 by coagulation factor concentratesM D Williams, B J Cohen, A C Beddall, et al.Journal of Clinical Microbiology|October 1, 1986
Detection of antibodies and antigens of human parvovirus B19 by enzyme-linked immunosorbent assayL J Anderson, C Tsou, R A Parker, et al.Pageof 69